Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy
2017 · Gut · 197 citations
https://doi.org/10.1136/gutjnl-2017-314032
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
35
Papers
1.3K
Citations
16
h-index
16
i10-index
Yu Feng is an academic researcher from Central South University of Forestry and Technology. The author has contributed to research in topics: Immune cells in cancer & Cancer Immunotherapy and Biomarkers & Immune Cell Function and Interaction. The author has an h-index of 16, co-authored 30 publications.
ORCID: 0000-0001-8358-8740Papers by this author
worksSpatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients
2024 · Nature Communications · 51 citations
https://doi.org/10.1038/s41467-024-54710-3
Cell cycle-related kinase reprograms the liver immune microenvironment to promote cancer metastasis
2020 · Cellular and Molecular Immunology · 44 citations
https://doi.org/10.1038/s41423-020-00534-2
A network pharmacology-based study on the anti-hepatoma effect of Radix Salviae Miltiorrhizae
2019 · Chinese Medicine · 43 citations
https://doi.org/10.1186/s13020-019-0249-6
scMMAE: masked cross-attention network for single-cell multimodal omics fusion to enhance unimodal omics
2024 · Briefings in Bioinformatics · 4 citations
https://doi.org/10.1093/bib/bbaf010
RETRACTED: Natural gas price prediction based on artificial intelligence models
2025 · PLoS ONE · 0 citations
https://doi.org/10.1371/journal.pone.0336582
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat